NCT00466297 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Reeves S, Russell A, Zwarenstein M, Kenaszchuk C, Conn LG, Doran D, Sinclair L, Lingard L, Oandasan I, Thorpe K, Austin Z, Beales J, Hindmarsh W, Whiteside C, Hodges B, Nasmith L, Silver I, Miller KL, Vogwill V, Strauss S
Structuring communication relationships for interprofessional teamwork (SCRIPT): a Canadian initiative aimed at improving patient-centred care. J Interprof Care. 2007 Feb;21(1):111-4.

The SCRIPT Programme (GIM): Structuring Communication Relationships for Interprofessional Teamwork to Achieve Interprofessional Education for Collaborative Patient-Centered Practice (IECPCP)

Details for clinical trial NCT00466297

Clinical trial NCT00466297 - References